323 related articles for article (PubMed ID: 17254959)
21. PRAK suppresses oncogenic ras-induced hematopoietic cancer development by antagonizing the JNK pathway.
Yoshizuka N; Lai M; Liao R; Cook R; Xiao C; Han J; Sun P
Mol Cancer Res; 2012 Jun; 10(6):810-20. PubMed ID: 22665523
[TBL] [Abstract][Full Text] [Related]
22. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
23. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
24. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
25. Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes.
Cotarelo CL; Schad A; Kirkpatrick CJ; Sleeman JP; Springer E; Schmidt M; Thaler S
Oncotarget; 2016 Nov; 7(46):74846-74859. PubMed ID: 27713152
[TBL] [Abstract][Full Text] [Related]
26. CDK2 transcriptional repression is an essential effector in p53-dependent cellular senescence-implications for therapeutic intervention.
Zalzali H; Nasr B; Harajly M; Basma H; Ghamloush F; Ghayad S; Ghanem N; Evan GI; Saab R
Mol Cancer Res; 2015 Jan; 13(1):29-40. PubMed ID: 25149358
[TBL] [Abstract][Full Text] [Related]
27. Another "Janus paradox" of p53: induction of cell senescence versus quiescence.
Darzynkiewicz Z
Aging (Albany NY); 2010 Jun; 2(6):329-30. PubMed ID: 20603525
[No Abstract] [Full Text] [Related]
28. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
[TBL] [Abstract][Full Text] [Related]
29. Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors.
Horiguchi M; Koyanagi S; Okamoto A; Suzuki SO; Matsunaga N; Ohdo S
Cancer Res; 2012 Jan; 72(2):395-401. PubMed ID: 22102693
[TBL] [Abstract][Full Text] [Related]
30. ZNF768 links oncogenic RAS to cellular senescence.
Villot R; Poirier A; Bakan I; Boulay K; Fernández E; Devillers R; Gama-Braga L; Tribouillard L; Gagné A; Duchesne É; Caron D; Bérubé JS; Bérubé JC; Coulombe Y; Orain M; Gélinas Y; Gobeil S; Bossé Y; Masson JY; Elowe S; Bilodeau S; Manem V; Joubert P; Mallette FA; Laplante M
Nat Commun; 2021 Aug; 12(1):4841. PubMed ID: 34404770
[TBL] [Abstract][Full Text] [Related]
31. Regulation of p53 responses by post-translational modifications.
Xu Y
Cell Death Differ; 2003 Apr; 10(4):400-3. PubMed ID: 12719715
[No Abstract] [Full Text] [Related]
32. A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3.
Lahtela J; Corson LB; Hemmes A; Brauer MJ; Koopal S; Lee J; Hunsaker TL; Jackson PK; Verschuren EW
Cell Cycle; 2013 Feb; 12(4):625-34. PubMed ID: 23324396
[TBL] [Abstract][Full Text] [Related]
33. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
34. mTOR favors senescence over quiescence in p53-arrested cells.
Schug TT
Aging (Albany NY); 2010 Jun; 2(6):327-8. PubMed ID: 20603524
[No Abstract] [Full Text] [Related]
35. Depletion of CSN5 inhibits Ras-mediated tumorigenesis by inducing premature senescence in p53-null cells.
Tsujimoto I; Yoshida A; Yoneda-Kato N; Kato JY
FEBS Lett; 2012 Dec; 586(24):4326-31. PubMed ID: 23127558
[TBL] [Abstract][Full Text] [Related]
36. IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases.
Choubey D; Panchanathan R
Ageing Res Rev; 2016 Jul; 28():27-36. PubMed ID: 27063514
[TBL] [Abstract][Full Text] [Related]
37. Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition.
Jiang Y; Xie X; Li Z; Wang Z; Zhang Y; Ling ZQ; Pan Y; Wang Z; Chen Y
Cancer Res; 2011 Apr; 71(8):2959-68. PubMed ID: 21385899
[TBL] [Abstract][Full Text] [Related]
38. Twenty years of p53 research: structural and functional aspects of the p53 protein.
May P; May E
Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
[No Abstract] [Full Text] [Related]
39. Detection of Oncogene-Induced Senescence In Vivo.
Baek KH; Ryeom S
Methods Mol Biol; 2017; 1534():185-198. PubMed ID: 27812880
[TBL] [Abstract][Full Text] [Related]
40. Induction of cellular senescence by oncogenic RAS.
Gupta R; Wajapeyee N
Methods Mol Biol; 2013; 1048():127-33. PubMed ID: 23929102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
